Home › Neurologic Diseases › New Jersey
Neurologic Diseases clinical trials in New Jersey
7 studies for Neurologic Diseases are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192Product Surveillance Registry
- Camden
- Marlton
- Morristown
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Marlton
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Aug 24, 2026 · NCT06297590Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
- Kessler Foundation, West Orange
Recruiting
Ages 18 to 75 · All sexes · Updated Sep 2, 2025 · NCT05725499Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
- Kessler Foundation, West Orange
Recruiting
Ages 18 to 75 · All sexes · Updated Sep 2, 2025 · NCT05731986From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.